Organon And Co
Clinical trials sponsored by Organon And Co, explained in plain language.
-
New cream shows promise for controlling severe eczema flares
Disease control CompletedThis study tested a new topical cream called tapinarof for people with moderate to severe eczema (atopic dermatitis). Over 400 children and adults applied the cream or a placebo once daily for 8 weeks to see if it could clear or nearly clear their skin and reduce itching. The goa…
Phase: PHASE3 • Sponsor: Organon and Co • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New eczema cream tested for safety in kids
Disease control CompletedThis study tested the safety and how much of a new topical cream called tapinarof gets into the body when used by children with widespread atopic dermatitis (eczema). 36 children aged 2 to 17 applied the cream daily for 4 weeks. The main goal was to check for side effects and mea…
Phase: PHASE2 • Sponsor: Organon and Co • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Two drugs beat one in fight against dangerous cholesterol
Disease control CompletedThis study tested if starting two cholesterol-lowering drugs together works better than one for people at very high risk of heart attack or stroke. It compared the combination of ezetimibe and atorvastatin against atorvastatin alone in 137 patients. The main goal was to see which…
Phase: PHASE4 • Sponsor: Organon and Co • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New cream shows promise for clearing stubborn eczema
Disease control CompletedThis study tested a once-daily cream called tapinarof for people with moderate to severe eczema. Over 400 children and adults used the cream or a placebo for 8 weeks to see if it could clear or nearly clear their skin. The main goal was to see if the active cream was more effecti…
Phase: PHASE3 • Sponsor: Organon and Co • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Birth control implant tested for two extra years of protection
Prevention CompletedThis study tested whether a birth control implant remains effective and safe for two years longer than its current approval. It involved nearly 500 women aged 35 or younger who had already used the implant for three years. The goal was to see if the implant could reliably prevent…
Phase: PHASE3 • Sponsor: Organon and Co • Aim: Prevention
Last updated Mar 30, 2026 14:31 UTC